Physiogenomics and Diabetes
Host: Leslie P. Lundt, MD Guest: Gualberto Ruano, MD, PhD Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Clinician's Roundtable?
This episode is 13 minutes long.
When was this Clinician's Roundtable episode published?
This episode was published on October 29, 2007.
Can I download this Clinician's Roundtable episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.